Drugs / HUFF-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06361433 | Dec 2023 → Feb 2026 | intracerebral hemorrhage | Hokkaido University Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HUFF-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06361433 ↗ |
| Modality | Cell therapy | “intracerebral transplantation of stem cell product” NCT06361433 ↗ |
| Route | Other | “through stereotactic transplantation into the hemorrhagic cavity” NCT06361433 ↗ |